1. Blute, ML. Transurethral Microwave Thermotherapy: Minimally Invasive Therapy for Benign Prostatic Hyperplasia. Urology 50(2): 163-166, 1997 (August).
   
   Recent editorial review from a Mayo Clinic urologist, who was among the U.S. pioneers in use of the Prostatron.
   
   Conclusion: "TUMT fills the gap betweeen medical and surgical therapy for BPH, being easily tolerated without the side effects of medicine or risks of surgery."
   
   
   
2. de la Rosette JJ, D'Ancona FC, Debruyne FM. Current status of thermotherapy of the prostate. J Urol 157(2): 430-438, 1997.
   
   An update and comprehensive literature review from a Dutch urologist who was among the first in the world to work with the Prostatron.
   
   Conclusion: "Numerous studies unequivocally support the efficacy and safety of transurethral microwave thermotherapy for treatment of symptomatic BPH. Significant improvement in objective and subjective parameters has been realized with transurethral microwave thermotherapy at multiple centers in the United States and Europe."
   
   
   
3. Ahmed M, Bell T, Lawrence WT, Ward JP, Watson GM. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study.
   
   Br J Urol 79(2): 181-185, 1997.
   
   This well-designed study from England resulted in disappointing objective results for TUMT, and it serves to remind that the final word is not yet in.
   
   Conclusion: "Despite considerable improvement in their symptoms, TUMT ... did not alleviate obstruction in patients with BPH. Patients treated using TUMT ... should be informed of the possibility of ejaculatory dysfunction (seen in 4/18 men)."
   
   

Note: These references were obtained from a Medline search of the medical literature, which is available to any user free of charge via the Internet at:
http://www4.ncbi.nlm.nih.gov/PubMed/